Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

American Biological Technologies

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of immunological reagents. The company is engaged in the production of contract manufactured in vitro diagnostic controls and reagents, human and animal serums, diagnostic assay controls, and calibrators.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Fujirebio Diagnostics
Primary Office
  • 940 Crossroads Boulevard
  • Seguin, TX 78155
  • United States

American Biological Technologies Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore American Biological Technologies‘s full profile, request access.

Request full access to PitchBook

American Biological Technologies Executive Team (1)

Name Title Board
Seat
Contact
Info
Michael Schrage President